| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a63fd6b39df9d39d46c56910ebcd928f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fa498ff7a861dda0231fcd182034f9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bee94bd19ccbba70428e5d72bab8df15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3efe760d152a23c991ecf6347b7fb1c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate |
2000-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b6c4bf4d9c516a9273a7104b9964bea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a008747c710b03973dbc0806bf6cc65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ea67c3fbb8b13d9137653942d6a8b9a |
| publicationDate |
2001-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0127262-A1 |
| titleOfInvention |
Gene selection using pnas |
| abstract |
The invention concerns novel drugs for use in combating infectious micro-organisms, in particular bacteria. More particular the invention concerns peptide nucleic acid (PNA) sequences which are modified by conjugating cationic peptides to the PNA in order to obtain novel PHA molecules with enhanced anti-infective properties. The PNA sequences ae used in a method for identifying one or more target genes in a micro-organism such as E.coli, for developing an anti-infective treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101891804-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1534837-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101891804-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1534837-A4 |
| priorityDate |
1999-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |